Ceftazidime Chemische Eigenschaften,Einsatz,Produktion Methoden
R-Sätze Betriebsanweisung:
R42/43:Sensibilisierung durch Einatmen und Hautkontakt möglich.
S-Sätze Betriebsanweisung:
S22:Staub nicht einatmen.
S36/37:Bei der Arbeit geeignete Schutzhandschuhe und Schutzkleidung tragen.
S45:Bei Unfall oder Unwohlsein sofort Arzt zuziehen (wenn möglich, dieses Etikett vorzeigen).
S37:Geeignete Schutzhandschuhe tragen.
S24:Berührung mit der Haut vermeiden.
Beschreibung
Ceftazidime is the latest third generation cephalosporin to reach the market. It
has one of the broadest spectrums of the cephalosporins, similar in many regards
to that of cefotaxime. It is particularly active against Pseudomonas aeruginosa,
being perhaps 4-5 times more potent in vitro than moxalactam and cefotaxime.
Chemische Eigenschaften
White Solid
Verwenden
Ceftazidime pentahydrate is an antibacterial agent. It is used especially for Pseudomonas and other gram-negative infections in debilitated patients. It is used in the treatment of patients with infections caused by susceptible strains of organisms in the following diseases: lower respiratory tract infections,skin and skin structure infections, urinary tract infections, bacterial septicemia, bone and joint infections, gynecologic infections, intra abdominal infections (including peritonitis), and central nervous system infections (including meningitis).
Definition
ChEBI: A hydrate that is the pentahydrate of ceftazidime, a cephalosporin having 7beta-[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-{[(2-carboxypropan-2-yl)oxy]imino}acetyl]amino and 3-pyridinium-1-ylmethyl side-groups.
Antimicrobial activity
Its activity is comparable to that of cefotaxime
and ceftizoxime, but it is more active against Ps. aeruginosa,
including almost all gentamicin-resistant strains, and Burk.
cepacia. It is, however, less active against Staph. aureus. It is stable to a wide range of β-lactamases, but is hydrolyzed by
some TEM variants.
Clinical Use
It is used, often combined with an aminoglycoside, to treat
a wide range of severe urinary, respiratory and wound infections,
mostly due to enterobacteria or Ps. aeruginosa. Reference
is made to its use in pneumonia, septicemia, meningitis (especially
if caused by Ps. aeruginosa), peritonitis, osteomyelitis,
neonatal sepsis, burns and melioidosis. Concern has been
expressed at the relative frequency with which failure is associated
with superinfection or the emergence of resistance.
Nebenwirkungen
It is generally well tolerated. Preparations containing arginine
have replaced those with sodium carbonate, which causes
pain on intramuscular injection. Reactions common to cephalosporins
have been observed in some patients, including positive
antiglobulin tests without hemolysis, raised liver function
test values, eosinophilia, rashes, leukopenia, thrombocytopenia
and diarrhea, occasionally associated with toxigenic
C. difficile.
Failure of therapy has been associated with superinfection
with resistant organisms, including Staph. aureus, enterococci
and Candida. Resistance caused by induction of chromosomal
β-lactamases may emerge in Ps. aeruginosa, Ser. marcescens or
Enterobacter spp.
Ceftazidime Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte
